Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 136

1.

Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana.

Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Lockman S, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S.

Genes (Basel). 2018 Sep 7;9(9). pii: E453. doi: 10.3390/genes9090453.

2.

In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm.

Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Makhema J, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S.

Genes (Basel). 2018 Aug 21;9(9). pii: E420. doi: 10.3390/genes9090420.

3.

Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.

Mupfumi L, Moyo S, Molebatsi K, Thami PK, Anderson M, Mogashoa T, Iketleng T, Makhema J, Marlink R, Kasvosve I, Essex M, Musonda RM, Gaseitsiwe S.

PLoS One. 2018 Jun 1;13(6):e0198711. doi: 10.1371/journal.pone.0198711. eCollection 2018.

4.

Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.

Diphoko T, Gaseitsiwe S, Kasvosve I, Moyo S, Okatch H, Musonda R, Wainberg M, Makhema J, Marlink R, Novitsky V, Essex M.

AIDS Res Hum Retroviruses. 2018 Aug;34(8):667-671. doi: 10.1089/AID.2017.0135. Epub 2018 Jun 12.

PMID:
29732907
5.

Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.

Mupfumi L, Moyo S, Molebatsi K, Thami PK, Anderson M, Mogashoa T, Iketleng T, Makhema J, Marlink R, Kasvosve I, Essex M, Musonda RM, Gaseitsiwe S.

PLoS One. 2018 Jan 31;13(1):e0192030. doi: 10.1371/journal.pone.0192030. eCollection 2018. Erratum in: PLoS One. 2018 Jun 1;13(6):e0198711.

6.

The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana.

N'Guessan KF, Anderson M, Phinius B, Moyo S, Malick A, Mbangiwa T, Choga WT, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT.

Open Forum Infect Dis. 2017 Oct 10;4(4):ofx222. doi: 10.1093/ofid/ofx222. eCollection 2017 Fall.

7.

The effect of micronutrient supplementation on active TB incidence early in HIV infection in Botswana.

Campa A, Baum MK, Bussmann H, Martinez SS, Farahani M, van Widenfelt E, Moyo S, Makhema J, Essex M, Marlink R.

Nutr Diet Suppl. 2017;2017(9):37-45. doi: 10.2147/NDS.S123545. Epub 2017 Jul 14.

8.

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana.

Ryan K, Anderson M, Gyurova I, Ambroggio L, Moyo S, Sebunya T, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT.

Open Forum Infect Dis. 2017 Sep 13;4(4):ofx195. doi: 10.1093/ofid/ofx195. eCollection 2017 Fall.

9.

Urgently Creating the Better in Global Health.

Marlink R.

Hastings Cent Rep. 2017 Sep;47(5):25-26. doi: 10.1002/hast.765.

PMID:
28940350
10.

Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.

Xie W, Agniel D, Shevchenko A, Malov SV, Svitin A, Cherkasov N, Baum MK, Campa A, Gaseitsiwe S, Bussmann H, Makhema J, Marlink R, Novitsky V, Lee TH, Cai T, O'Brien SJ, Essex M.

AIDS Res Hum Retroviruses. 2017 Jun;33(6):597-609. doi: 10.1089/AID.2016.0017. Epub 2017 Apr 6.

11.

Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.

Anderson M, Gaseitsiwe S, Moyo S, Thami KP, Mohammed T, Setlhare D, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM.

Open Forum Infect Dis. 2016 Aug 16;3(3):ofw140. eCollection 2016 Sep.

12.

Impact of Health System Inputs on Health Outcome: A Multilevel Longitudinal Analysis of Botswana National Antiretroviral Program (2002-2013).

Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld AF, Nkomazana O, Marlink R.

PLoS One. 2016 Aug 4;11(8):e0160206. doi: 10.1371/journal.pone.0160206. eCollection 2016.

13.

Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana.

Moyo S, Kotokwe KP, Mohammed T, Boleo C, Mupfumi L, Chishala S, Tsalaile L, Bussmann H, Gaseitsiwe S, Musonda R, Makhema J, Baum M, Marlink R, Engelbrecht S, Essex M, Novitsky V.

AIDS Res Hum Retroviruses. 2017 Jan;33(1):17-18. doi: 10.1089/AID.2016.0127. Epub 2016 Sep 7.

14.

Wide Variations in Compliance with Tuberculosis Screening Guidelines and Tuberculosis Incidence between Antiretroviral Therapy Facilities - Côte d'Ivoire.

Auld AF, Blain M, Ekra KA, Kouakou JS, Ettiègne-Traoré V, Tuho MZ, Mohamed F, Shiraishi RW, Sabatier J, Essombo J, Adjorlolo-Johnson G, Marlink R, Ellerbrock TV.

PLoS One. 2016 Jun 8;11(6):e0157059. doi: 10.1371/journal.pone.0157059. eCollection 2016.

15.

Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana.

Martinez SS, Campa A, Bussmann H, Moyo S, Makhema J, Huffman FG, Williams OD, Essex M, Marlink R, Baum MK.

Br J Nutr. 2016 Jun;115(12):2114-21. doi: 10.1017/S0007114516001409. Epub 2016 Apr 18.

16.

Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis.

Farahani M, Mulinder H, Farahani A, Marlink R.

Int J STD AIDS. 2017 Jun;28(7):636-650. doi: 10.1177/0956462416632428. Epub 2016 Feb 10. Review.

PMID:
26868158
17.

How providers influence the implementation of provider-initiated HIV testing and counseling in Botswana: a qualitative study.

Ahmed S, Bärnighausen T, Daniels N, Marlink R, Roberts MJ.

Implement Sci. 2016 Feb 11;11:18. doi: 10.1186/s13012-015-0361-7.

18.

Recruitment, Follow-Up and Characteristics of HIV Infected Adults who Use Illicit Drugs in Southern Africa.

Baum MK, Campa A, Page JB, Lai S, Tsalaile L, Martinez SS, Burns P, Williams O, Li Y, van Widenfelt E, Bussmann H, Sikhulele M, Makhema J, Essex M, Marlink R.

J Drug Abuse. 2015;1(1). pii: 7. Epub 2015 Dec 8.

19.

Prognostic Value of HIV-1 RNA on CD4 Trajectories and Disease Progression Among Antiretroviral-Naive HIV-Infected Adults in Botswana: A Joint Modeling Analysis.

Farahani M, Novitsky V, Wang R, Bussmann H, Moyo S, Musonda RM, Moeti T, Makhema JM, Essex M, Marlink R.

AIDS Res Hum Retroviruses. 2016 Jun;32(6):573-8. doi: 10.1089/AID.2015.0348. Epub 2016 Mar 3.

20.

Trends and determinants of survival for over 200 000 patients on antiretroviral treatment in the Botswana National Program: 2002-2013.

Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld A, Nkomazana O, Marlink R.

AIDS. 2016 Jan 28;30(3):477-85. doi: 10.1097/QAD.0000000000000921.

Supplemental Content

Loading ...
Support Center